Understanding vulnerabilities and resilience in binge eating disorder among female population and transgender individuals across the lifespan: a narrative review
Abstract
Binge eating disorder (BED) represents a significant public health concern due to its multifaceted physical, psychological, and economic consequences, all of which substantially impair the quality of life of affected individuals. Individuals with BED often experience persistent body dissatisfaction, emotional distress, anxiety, depression, chronic stress, and social prejudice. Fear of judgment, stigmatisation, and discrimination frequently leads to delays in, or complete avoidance of, seeking medical or psychological support. Although BED remains largely underdiagnosed, existing literature indicates a higher prevalence among females. Nevertheless, the factors contributing to its onset remain insufficiently explored, despite the well-documented vulnerability of women throughout various life stages. Specifically, gendered social roles and ongoing hormonal fluctuations are known to influence emotional regulation, potentially triggering and sustaining binge eating behaviours. This narrative review explores the prevalence and associated factors of BED in the female population across the lifespan, including childhood, adolescence, pregnancy, and menopause. It also considers the transgender population, acknowledging how gender identity, stigma, discrimination, and hormonal treatments can influence BED risk and presentation. Moreover, studies highlighted that the risk and maintenance of BED are exacerbated at various life stages by biological changes associated with sex, as well as…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.